Imbria Pharmaceuticals
Imbria Pharmaceuticals develops innovative therapies that target cardiometabolic disorders by leveraging insights from cellular metabolism. The company focuses on creating medicines that aim to improve the lives of patients suffering from these conditions. By translating scientific research into practical treatments, Imbria addresses significant unmet medical needs in the cardiometabolic space. Their research efforts are directed towards understanding the underlying mechanisms of disease, which informs the development of their therapeutic candidates. Through this approach, Imbria Pharmaceuticals contributes to advancing healthcare solutions for individuals affected by cardiometabolic issues.
Tech Stack (22 technologies)
Frequently Asked Questions
What technologies does Imbria Pharmaceuticals use?+
Imbria Pharmaceuticals uses 22 technologies including Astra, Elementor, Google Analytics.
What industry is Imbria Pharmaceuticals in?+
Imbria Pharmaceuticals operates in the Biotechnology industry.
Where is Imbria Pharmaceuticals based?+
Imbria Pharmaceuticals is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026